Literature DB >> 18722943

Surgery for gallbladder cancer: a population-based analysis.

Natalie G Coburn1, Sean P Cleary, Jensen C C Tan, Calvin H L Law.   

Abstract

BACKGROUND: Gallbladder cancer is an aggressive neoplasm, and resection is the only curative modality. Single institutional studies report an aggressive surgical approach improves survival. This analysis was performed to examine the components of surgical resection and resultant survival. STUDY
DESIGN: From 1988 to 2003, patients aged 18 to 85 years, resected of T1-3 M0 gallbladder cancer, were identified from the Surveillance, Epidemiology, and End Results (SEER) registry. Resections were classified as en bloc (cholecystectomy + at least one adjacent organ) or simple (cholecystectomy only); lymphadenectomy was defined as three or more lymph nodes assessed.
RESULTS: Of the 2,835 resected patients with T1-T3 M0 cancer, only 8.6% underwent an en bloc resection, and 5.3% had a lymphadenectomy. In multivariable analysis, age, year of resection, region, and advanced T-stage were associated with more aggressive resection. In univariate analysis, improved survival was associated with en bloc resection for T1/2 cancers, and lymphadenectomy for T2/3 cancers. In multivariable analysis, the following were associated with improved survival: for T1 cancers, en bloc resection, younger age, lower grade, and recent year of resection; for T2 cancers, Caucasian race (versus African-American), lower grade, and node negative disease, with trends for en bloc resection and lymphadenectomy; and for T3 cancers, female gender, Caucasian race (versus American Indian), lower grade, node negative disease, and recent year of resection, with a strong trend for lymphadenectomy.
CONCLUSIONS: Very few patients underwent aggressive surgery. En bloc resection and lymphadenectomy may have stage-specific effects on survival. Additional studies should explore the underuse of aggressive operations, verify survival advantages, and define stage-specific resection strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18722943     DOI: 10.1016/j.jamcollsurg.2008.02.031

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  43 in total

1.  Postoperative chemoradiotherapy for gallbladder cancer.

Authors:  K Kim; E K Chie; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

2.  Early gallbladder carcinoma has a favorable outcome but Rokitansky-Aschoff sinus involvement is an adverse prognostic factor.

Authors:  Juan C Roa; Oscar Tapia; Carlos Manterola; Miguel Villaseca; Pablo Guzman; Juan Carlos Araya; Pelin Bagci; Burcu Saka; Volkan Adsay
Journal:  Virchows Arch       Date:  2013-09-11       Impact factor: 4.064

3.  Role of cholecystectomy and lymph node dissection in patients with T2 gallbladder cancer.

Authors:  Dong Hyun Kim; Sung Hoon Kim; Gi Hong Choi; Chang Moo Kang; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

4.  Gallbladder cancer: expert consensus statement.

Authors:  Thomas A Aloia; Nicolas Járufe; Milind Javle; Shishir K Maithel; Juan C Roa; Volkan Adsay; Felipe J F Coimbra; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

5.  Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain.

Authors:  Ruhi Dixit; Mohd Raza; Mohan Kumar; S Basu; V K Shukla
Journal:  J Gastrointest Cancer       Date:  2018-12

6.  Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study.

Authors:  Woohyung Lee; Chi-Young Jeong; Young Hoon Kim; Young Hoon Roh; Myung Hee Yoon; Hyung Il Seo; Jeong-Ik Park; Bo-Hyun Jung; Dong Hoon Shin; Young Il Choi; Je Ho Ryu; Kwang Ho Yang; Chang Soo Choi; Yo-Han Park; Yang Won Nah; Soon-Chan Hong
Journal:  Langenbecks Arch Surg       Date:  2019-08-14       Impact factor: 3.445

7.  Prognostic Impact of Lymph Node Excision in T1 and T2 Gallbladder Cancer: a Population-Based and Propensity Score-Matched SEER Analysis.

Authors:  Thomas Steffen; Sabrina M Ebinger; Ignazio Tarantino; Bernhard Widmann
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

Review 8.  Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis.

Authors:  Kui Sun Choi; Sae Byeol Choi; Pyoungjae Park; Wan Bae Kim; Sang Yong Choi
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

9.  MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.

Authors:  Xiang-Song Wu; Xu-An Wang; Wen-Guang Wu; Yun-Ping Hu; Mao-Lan Li; Qian Ding; Hao Weng; Yi-Jun Shu; Tian-Yu Liu; Lin Jiang; Yang Cao; Run-Fa Bao; Jia-Sheng Mu; Zhu-Jun Tan; Feng Tao; Ying-Bin Liu
Journal:  Cancer Biol Ther       Date:  2014-03-21       Impact factor: 4.742

10.  Gallbladder cancer: we need to do better!

Authors:  Parul J Shukla; Savio G Barreto
Journal:  Ann Surg Oncol       Date:  2009-06-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.